"Lay epidemiology": an important factor in Danish parents' decision of whether to allow their child to receive a BCG vaccination:A qualitative exploration of parental perspective by Thybo Pihl, Gitte et al.
Syddansk Universitet
"Lay epidemiology": an important factor in Danish parents' decision of whether to
allow their child to receive a BCG vaccination
A qualitative exploration of parental perspective
Thybo Pihl, Gitte; Johannessen, Helle; Ammentorp, Jette; Schmidt Jensen, Jane; Kofoed,
Poul-Erik
Published in:
BMC Pediatrics
DOI:
10.1186/s12887-017-0944-3
Publication date:
2017
Document version
Publisher's PDF, also known as Version of record
Document license
CC BY
Citation for pulished version (APA):
Thybo Pihl, G., Johannessen, H., Ammentorp, J., Schmidt Jensen, J., & Kofoed, P-E. (2017). "Lay
epidemiology": an important factor in Danish parents' decision of whether to allow their child to receive a BCG
vaccination: A qualitative exploration of parental perspective. BMC Pediatrics, 17(1), [194]. DOI:
10.1186/s12887-017-0944-3
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 08. Jan. 2018
RESEARCH ARTICLE Open Access
“Lay epidemiology”: an important factor in
Danish parents’ decision of whether to
allow their child to receive a BCG
vaccination. A qualitative exploration of
parental perspective
Gitte Thybo Pihl1,2*, Helle Johannessen2, Jette Ammentorp2,3, Jane Schmidt Jensen3 and Poul-Erik Kofoed1,2
Abstract
Background: Vaccination is used worldwide to prevent infectious diseases. However, vaccination programmes in
western countries face challenges in sustaining high coverage rates. The aim of this study was to explore how
parents in Denmark make a decision about whether to allow their child to receive a Bacille Calmette Guerin vaccine
at birth for the purpose of achieving non-specific effects on the immune system.
Methods: A total of five focus groups were conducted with expectant mothers and fathers. Written information
about the vaccine and information about the hypothesis of non-specific effects of the vaccine were delivered in
order to discuss considerations and determinants of parents’ decisions.
Results: Heritable factors and the possibility of stimulating the immune system of the child to achieve less atopic
diseases and fewer infections were identified as arguments in favour of receiving the BCG vaccine. Arguments
against receiving BCG mainly focused on concerns about its described and non-described side effects. Both
arguments for and arguments against the vaccine were seen as parents attempt to make an individual risk
evaluation for their child. Attitudes and beliefs in the local network were identified as important for parents’
decisions.
Discussion: It is discussed how “lay epidemiology” characterizes parents’ risk evaluation as an individual addition to
the population-based risk declaration. It is furthermore discussed how health professionals should engage with
both the empirical element and the value element of “Lay epidemiology”.
Conclusion: “Lay epidemiology” forms the basis for the parental decision of whether to allow their child to receive
a BCG vaccination. Attitudes and beliefs about the causes and distribution of illnesses in the family or local network
influence parents’ risk evaluations. It would be ideal for parents if health professionals focused their communication
about the BCG vaccine on individual risk evaluations.
Keywords: Decision making, Lay epidemiology, Risk evaluation, Patient-provider communication, Vaccine safety
concerns, Values, Heterologous immunity.
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Background
Vaccination is used worldwide to prevent infectious
diseases, and the establishment of vaccination pro-
grammes throughout the world is a major public
health achievement [1]. However, vaccination pro-
grammes in western countries face challenges in sus-
taining high coverage rates [http://www.who.int/immu
nization/research/implementation/en/]. The most com-
mon barrier to paediatric immunization is parental
concerns about the negative side effects of vaccines
[2–4]. In addition, some parents believe that the im-
mune system becomes stronger by being challenged
by the natural infectious disease, that the immune
system might be overwhelmed if exposed to too
many vaccines, or that additives in the vaccines
might be harmful [5]. Accordingly, paediatricians are
concerned if these barriers to vaccination are based
on an insufficient level of knowledge and how to ad-
dress and overcome these barriers [6]. Research that
has explored parental knowledge, attitudes, and
beliefs about vaccination suggests that health care
providers must support each individual parent in
making decisions about having their children immu-
nized [7]. Therefore, it is important to study parents’
considerations about vaccines in order to learn how
to support parental decision making.
The Bacille Calmette Guerin (BCG) vaccine has been
used for almost 100 years to prevent tuberculosis [8]
and is part of childhood immunization programmes in
many countries, but it was removed from the Danish
vaccination programme 30 years ago due to the low
prevalence of tuberculosis in Denmark. However,
epidemiological studies in Africa have found lower
mortality and morbidity and less atopic diseases among
children immunized with BCG [9–12]. Whether these
positive non-specific effects of BCG also occur in western
societies is being tested by a large prospective randomized
clinical trial in Denmark, the Danish Calmette Study
[http://calmette-studiet.dk/Om%20Studiet/Studiemateri
ale/Protokol.aspx]. The Danish Calmette Study is a
multicentre study with cooperation between Rigshospi-
talet in Copenhagen, Hvidovre and Kolding Hospitals.
The study was designed as a clinical trial with tele-
phone interviews, clinical investigations and register-
based follow-up [http://calmette-studiet.dk/Om%20Stu
diet/Studiemateriale/Protokol.aspx]. Even if this trial
gives convincing evidence of positive non-specific ef-
fects of BCG immunization, it might be difficult to im-
plement the BCG vaccine if parents are reluctant.
Therefore, before initiating the clinical trial, we investi-
gated how parents may make the decision of whether
to allow their child to receive a BCG vaccination at
birth, which is given to achieve possible non-specific ef-
fects on the immune system.
Methods
Participants and research setting
Before enrollment in the clinical trial began, five focus
groups were conducted with expectant mothers and
fathers for the purpose of discussing the considerations
for and against letting their new-born child be vaccinated
with BCG. Parents participating in antenatal classes at
Kolding Hospital during the summer of 2012 were invited
to the focus groups by one of the co-authors of this paper
(JSJ), who also facilitated the groups. Expectant mothers
were invited to participate in antenatal courses in the last
half of their pregnancy. Most first-time mothers and some
second-time mothers took the courses. Fathers were only
invited to participate in a few of the sessions.
In addition to the facilitator of the focus groups, one ob-
server was present. All sessions were audio-recorded with
written consent from the participants. The observer took
notes during the session to identify important themes and
arguments. Four focus groups were conducted with three,
eight, four and three expectant mothers, respectively, and
one focus group was conducted with four expectant fa-
thers. The reason for having separate focus groups was to
allow for different considerations of expectant mothers
and expectant fathers to be uncovered. Four of the partici-
pants were second-time mothers. One focus group with
expectant first-time fathers was conducted. The mean age
of participants was 28.9 years, with a minimum age of
23 years and a maximum age of 37 years. The socio-
economic background of the participants ranged from no
education to a college education and from no work to
working as a managing director.
Before the focus group started, the facilitator provided
written information on the BCG vaccine (Fig. 1) and the
aim of the Calmette Study (Fig. 2). The parents had time
to read the information and were then asked about their
considerations regarding whether to allow their new-
born child to be immunized with BCG and what would
determine their final decision.
The sessions were audio-recorded and transcribed
word-for-word. As described by Giorgi and Malterud
[13], the analysis process was started by gaining an over-
all impression of the data from all focus groups and then
identifying meaning units. After writing and reading all
meaning units, the units were categorized into three
groups: “arguments in favour of receiving the BCG
vaccine”, “arguments against receiving the BCG vaccine”
and “decisional conflicts”. The concept “lay epidemi-
ology” was used in the discussion to understand parental
risk evaluation.
Results
The results were categorized under three main themes,
with subheadings structuring the arguments under each
main theme.
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Arguments in favour of receiving the BCG vaccine
Statements in favour of receiving the BCG vaccine were
phrased very similar to that of the written information
about the Danish Calmette Study. When focusing on the
beneficial effects of the vaccine, the negative side effects
were considered to have minor importance. Other
favourable arguments focused on the fact that the
vaccine had been used for almost 100 years without
causing serious adverse events.
Stimulating the immune system
One group of arguments focused on the possible benefi-
cial effects of the BCG vaccine on the immune system,
which the participants related to concrete experiences
with illness and disease in their own family:
“There has really been a lot of disease in my part of
our family, so I think an augmented immune system
would be beneficial in my case.”.
“What captured my interest was this idea about the
immune system because I have had sinusitis twice a year.
I get sick from almost anything, so this [vaccine] would
definitely be interesting.”.
“... I'm a second-time mother, and when our first child
started day care, he was sick all the time, so if you could
do anything about that, I mean like with this vaccine,
then I would definitely think it could make a difference,
also in relation to quality of life when they are starting
in day care.”.
These reflections focused on experiences with disease
in the participants own families, including an improved
quality of life when children are less sick, and problems
regarding taking care of sick children when working.
Parents predicted the potency of the immune system of
their future child on the basis of experiences with sick-
ness in their own family.
Atopic disease
Similarly, parents predicted the risk of their future child
to suffer from asthma or eczema on the basis of experi-
ences in their own family.
“Now I know that my husband’s allergies and asthma
are heritable ... if it [the vaccine] can diminish the effect
on these heritable factors, I think it would be
important.”.
“No, I would not hesitate because I have both asthma,
allergies and eczema. So I would, if I could, I would do
everything possible for the child to avoid that. That is for
certain.”.
The parents knew that allergies and asthma are herit-
able. They argued that if the vaccine could decrease the
risk for their child to contract these disorders, despite
their hereditary nature, the vaccine would be beneficial.
Fig. 1 Description of the adverse reactions presented to the participants in the focus groups
Fig. 2 Background information presented to the participants in the focus groups
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‘Risk of negative side effects is negligible compared to the
possible benefits’
When speaking with parents about negative side effects
of the BCG vaccine, some considered the risk very low
compared to the possible benefits of the BCG vaccine.
“If there had been something other than these minor
wounds and then one out of 1000 getting an abscess or
so, that's nothing. If there had been something much
worse, if you could become hemiplegic after receiving it
or something crazy like that, then I think I would say no.
But there isn't. It is small events, and it is treatable.”.
An old, well-established vaccine
Many statements emphasized the fact that the BCG vac-
cine has been used for almost a century without causing
serious adverse reactions.
“I think it’s a good point, too, that it has been used for
so long without any incidences; nothing serious appeared.
That’s a heavy argument.”
Arguments against receiving the BCG vaccine
Parental arguments against BCG immunization mainly
focused on its negative side effects; however, the scar
caused by the vaccination and the fact that it might be
healthier or more safe to avoid being vaccinated were
also mentioned.
Concerns about side effects
Some of the participants were concerned about non-
described negative side effects, and this accounted for a
major part of the discussions in the focus groups. Below
are a few examples:
“If it had side effects that could not be readily treated
or that could cause serious injury, I would strongly
consider saying no.”
“I will not risk that my baby gets Down's syndrome
from a vaccine or gets some serious injury to the nervous
system or something like that.”.
Some parents feared that severe negative side effects
that health professionals had not considered may occur.
Furthermore, the parents expressed doubts about the
written information provided and asked whether there
could be more side effects than those described:
“What really makes me uncomfortable is … aren’t there
any more side effects than those written here? Is it then
because they don’t know if there are more side effects or
is it because they just want people to get the vaccine?
Well, you hear so much about how you trust people and
then are getting cheated in these TV programs.”
Finally, a few parents assessed the risk of the negative
side effects of the vaccine differently when the vaccination
was being used to achieve non-specific positive side effects
rather than to protect against a severe disease.
The scar
After BCG vaccination, most children develop a small
scar on their upper left arm at the vaccine injection site.
Some parents mention this scar as an argument against
vaccinating their children.
“The only thing that could keep me from doing this is
the wound and the scar afterwards. What will it look
like?”
A few parents argued that a cosmetic problem is sec-
ondary to the beneficial effect of the vaccine on the
immune system, but for others, the scar was a reason for
not allowing their children to be vaccinated.
It is more natural to avoid it
A few parents believe it is more natural to avoid vaccin-
ation; they implicitly understand avoiding vaccination as
healthier or safer.
“I think it's more natural to avoid the vaccine, and
then I just don't want to put that much into the body -
medicine and that kind.”.
Decisional conflicts
Two main themes appeared in the meaning units group
“decisional conflicts”: attitudes and beliefs in the parents’
network and the need for support from a health profes-
sional to make their decision.
Attitudes and beliefs in the network
Several parents stated that persons in their network hav-
ing had vaccination experiences with negative side ef-
fects and the attitudes of persons in their network would
greatly influence their decision about whether to allow
their child to be immunized.
“If someone had bad experiences with this vaccine, of
course it would affect me, especially if they were close to
me.”.
“I can understand that people refuse if they have a
close experience with these vaccines causing brain injury
or death, but what is the risk for oneself? I don't know.”.
It is remarkable, that the closeness of the persons that
had negative experiences to the parents has an impact
on the parents’ decision. Additionally, it seems that the
African research described in the written information
from the Danish Calmette Study was considered less
important.
“Research from developing countries, that's kind of far
away. We need something closer.”.
Help from a health professional to make a decision
When asked what would be crucial for making a deci-
sion, several parents stated that they needed to talk with
a health-professional.
“From what is written here I don't think the side effects
are something to worry about, but I would definitely ask
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more about it before I could make a decision. And then I
would ask about experiences.”.
A father in one of the focus groups read the written
information about the negative side effects of the BCG
vaccine and replied as follows:
“What is meant by ‘one in 1000’? I don’t know if my
child will be the one or one of the 999.”.
Discussion and conclusion
Discussion
“Lay epidemiology” in parental decision making
When analysing the data from the focus-groups, we real-
ized that many parents made a risk evaluation based on
the occurrence of sickness in their family and their net-
work to determine if their child could benefit from
BCG-immunization. The parents used cases from their
network and their family to develop a hunch of how
healthy or sick their expectant child would be. The cases
were used either as an argument for the vaccine or as an
argument against the vaccine.
By searching the literature for an understanding of this
phenomenon, the theory of “lay epidemiology” was
found to be quite helpful. The term “lay epidemiology”
is a theory of risk evaluation and shows how people per-
form a risk evaluation based on experiences in their net-
work. “Lay epidemiology” is defined by Davison et al. as:
“a scheme in which individuals interpret health risks
through the routine observation and discussion of cases
of illness and death in personal networks and in the
public arena, as well as from formal and informal
evidence arising from other sources, such as television
and magazines” [14]. Davison et al. showed how persons
in a local community in Wales interpret an individual’s
risk of developing a heart disease by observing and dis-
cussing the causes for contracting a heart disease in their
personal network and by evaluating cases described in
the press [14]. The closer a person’s relationship is to a
case and the greater the case’s similarity to their own
situation, the more weight they give to that case in their
own risk evaluation. The parents in the focus groups
made similar risk evaluations based on sickness and ad-
verse reactions to vaccines in their network and family.
“Lay epidemiology” as an individual addition to
population-based risk evaluation
How health professionals should engage with “lay epi-
demiology” has been widely discussed [15–18]. Several
authors have discussed “lay epidemiology” as a barrier to
public health messages, arguing that lay epidemiology
causes people to disregard health messages. In contrast,
Rose et al. discussed the fact that public health messages
are based on knowledge of populations but do not tell
an individual exactly how much he/she could benefit
from a change in lifestyle: “In mass prevention each
individual has usually only a small expectation of
benefit, and this small benefit can easily be outweighed
by a small risk” [19]. It is well understood in “lay epi-
demiology” that reducing the incidence of a disease in a
population is not the same as reducing the risk for each
individual person. “Lay epidemiology” can be seen as an
attempt to make a risk evaluation at the individual level,
whereas scientific epidemiology attempts to make a risk
evaluation at the population level. This is described very
precisely in the following statement: “What is meant by
‘one in 1000’? I don’t know if my child will be the one or
one of the 999.” In terms of “lay epidemiology”, this
statement could be seen as a father doubting the infor-
mation provided by the declaration of incidence about
the risk of his baby experiencing a negative side effect.
Thus, he asks for a more individual risk assessment.
One of the parents stated that he would ask the health
professional about his “experiences”. This could be seen
as a wish to make statistical information more concrete
and interpretable at the level of the individual.
“Experiences” describe individuals in real-life-situations,
whereas statistical information describes numbers and
cohorts. Hunt and Emslie expanded on the discussion of
“lay epidemiology” vs. scientific epidemiology. They
argue that context and complexity are considered im-
portant in “lay epidemiology”, while scientific epidemi-
ology attempts to simplify factors; this is described in
the following quote, “However, observations of the links
between a lifetime of experiences and subsequent health
events (including mortality) within the family offer the
lay epidemiologist potential for more complex theorizing
based on extensive and detailed knowledge about factors
or experiences which could increase risk, or be potential
confounders” [18]. Therefore, “lay epidemiology” should
not be seen as a barrier for public health messages, but
rather as an important addition to knowledge. Parents
assessing whether their child can benefit from the BCG
vaccine based on their experiences with diseases in their
own family can be seen as making a complex judgement
based on detailed knowledge of heritable factors in their
family. Conversely, some concerns about negative side
effects could be seen as completely unfounded, and the
question of how health professionals should deal with
this issue remains unclear.
Two importantly different elements in “lay epidemiology”
Allmark and Todd described how health professionals can
increase the effectiveness of public health messages by
focusing on two important elements of “lay epidemiology”:
the empirical element and the value element [20].
The empirical element consists of lay beliefs about
causes of illness and management of risk [20]. It recog-
nises that public health messages are sometimes exag-
gerated or even false, since prevention on a population
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level is not the same as prevention at the individual level
[19]. However, the empirical element in lay epidemiology
is based on incomplete beliefs and might sometimes
result in false conclusions [20]. Hence, scientific epi-
demiology is necessary to help prevent such false con-
clusions. An obvious example of a false conclusion is a
parent’s fear of their child developing Down’s syndrome
as a negative side effect of a vaccine. To correct parents’
concerns about negative side effects, it is important to
discuss their beliefs and to recognize them as important
to the parents. Because some parents question whether
additional negative side effects other than those de-
scribed by health professionals may occur, it is important
to avoid claiming that scientific knowledge is the only
and whole truth. Instead, health professionals should ex-
plain to parents that the scientifically based information
about negative side effects is the best knowledge we have
at present and should be willing to discuss the limita-
tions of this knowledge. Health professionals can correct
the conclusion that a baby can get Down’s syndrome
from a vaccine, but concerns about long-term side ef-
fects of vaccines are more difficult to reject due to the
lack of evidence of long-term side effects. Health profes-
sionals can explain the scientific rationale behind vaccin-
ation and then allow the parents to evaluate the
information for themselves.
The value element of “lay epidemiology” consists of
“values about the place of health and risks to health in a
good life” [20]. It is also considered an “all-things-consid-
ered” view, where personal values and the person’s entire
life-situation are considered. The aversion toward put-
ting drugs and vaccines into the body that some parents
express is related to their values, as is the consideration
of the scar that develops after BCG vaccination as a
major or minor side effect. Values are personal and re-
quire respect. Respect is necessary to conduct a dialogue
about personal values.
Thus, is it important to recognize both the respectful
dialogue about the value element and the need for cor-
rection to the empirical element of “lay epidemiology”
when parents ask for help from a health professional in
making decisions about vaccination. It is important to
consider “lay epidemiology” as an attempt of parents to
make an extensive individual risk evaluation for their
child. The health professional can be seen as an expert
counselling the parents to evaluate and correct their “lay
epidemiology” with help from scientific epidemiology.
Limitations
The focus group method for data collection is beneficial
for exploring what people think of a health intervention
and why [21]. Data are generated through interactions
between the group members as they exchange attitudes
and beliefs. Thus, the size of a focus group should be
small enough for the members to be comfortable speak-
ing but large enough to maintain group interactions. It
can be argued that three or four member focus groups
are too small; nevertheless, in this study, audio record-
ings and transcribed interviews demonstrated that group
interactions occurred in the focus groups.
The small sample size of this study implies that the
groups might not be representative of all expectant par-
ents. Thus, the findings of this study should not be con-
sidered a complete list of arguments but, rather as
examples of how some expectant parents make the deci-
sion of whether to vaccinate their child with BCG and
their arguments for and against it. These findings might
be useful for understanding parental decision making in
regards to the BCG vaccine in general. Likewise the par-
ents’ use of “lay epidemiology” in their risk evaluation
might be relevant for the understanding of parental deci-
sion making regarding vaccines in general.
Conclusion
Arguments in favour of receiving BCG vaccination are
based on the possible beneficial effects of the vaccine on
the immune system and that BCG is an old, well-
established vaccine.
The findings of this study corroborate the results of
studies in other western countries regarding parental
concerns about undescribed negative side effects of vac-
cines and vaccine safety [2–4]. In addition, some parents
were concerned about the scar caused by BCG
immunization, whereas others evaluated the scar as a
minor negative side effect compared to the possible
beneficial effects of the vaccine.
The focus group research here suggests that “lay epi-
demiology” may form the basis for the parental decision
of whether to allow their child to receive a BCG vaccin-
ation. Parents use their own interpretation of infections
and atopic diseases that have occurred in their family to
evaluate the risk of their child developing asthmatic
bronchitis, eczema or other allergies or infectious dis-
eases. This detailed knowledge about heritable factors
should be seen as valuable additional knowledge by the
health professional. Therefore, it would be ideal for par-
ents if health professionals base their communication
about the BCG vaccine on the parents’ individual risk
evaluation.
It appears, based on the focus group discussions, that
attitudes and beliefs about the causes and distribution of
an illness within the parents’ families or their local net-
work may influence the parents’ evaluation of the risk of
their future child becoming sick. They also impact their
assessment of the probability of negative side effects.
Some of the concerns parents have about negative side
effects could be considered unfounded.
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A bad experience with negative side effects in a par-
ent’s network bears more weight to that parent the
closer the case is to the parent and the more similar it is
to the situation of the parent. Therefore, when commu-
nicating with parents about vaccines, it may be beneficial
for health professionals to ask parents about their con-
cerns about and experiences with negative side effects.
Several parents emphasized that they need to talk with
a health professional to make their decision, not because
they need more information, but because they need help
evaluating their individual risk based on “lay epidemi-
ology”. It is important to recognize both the value elem-
ent of “lay epidemiology” and the need for correction to
the empirical element of “lay epidemiology” when health
professionals counsel parents in making their decision
about vaccines.
Practice implications
“Lay epidemiology” promotes the understanding of how
parents attempt to make an individual risk evaluation
for their future child when deciding whether to allow
their child to receive a BCG vaccine for the purpose of
achieving non-specific effects on the immune system. In
Denmark, the results may contribute to the understand-
ing of suboptimal vaccination coverage rates of other
vaccines as well. Accordingly, it is recommended that
health professionals include this individual risk evalu-
ation in their communication with parents not only
about BCG, but other vaccines as well, and that they
recognize both the empirical and the value element of
“lay epidemiology”.
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